538
Views
11
CrossRef citations to date
0
Altmetric
Clinical Research

The effect of a more strict 2014 DEA schedule designation for hydrocodone products on opioid prescription rates in the United States

ORCID Icon &
Pages 1064-1072 | Received 08 Nov 2018, Accepted 16 Jan 2019, Published online: 21 Feb 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Alice Wu, Christine Phan, Kim Chi Nguyen, Melvin Quindoy, Justin Lewis & Dorie E. Apollonio. (2021) Trends in hydrocodone combination product exposures reported to California Poison Control System (CPCS) following DEA rescheduling. Clinical Toxicology 59:4, pages 313-319.
Read now

Articles from other publishers (10)

Tesfahun C. Eshetie, Zachary A. Marcum, Kenneth E. Schmader & Shelly L. Gray. (2021) Medication use quality and safety in older adults: 2020 update. Journal of the American Geriatrics Society 70:2, pages 389-397.
Crossref
Leslie Mukau, Kadia Wormley, Christian Tomaszewski, Bushra Ahmad, Rais Vohra & Andrew Herring. (2022) Buprenorphine for High-dose Tramadol Dependence: A Case Report of Successful Outpatient Treatment. Clinical Practice and Cases in Emergency Medicine 6:1, pages 71-74.
Crossref
Jonathan P. Caulkins, Laura A. Goyeneche, Lingrong Guo, Kathryn Lenart & Michael Rath. (2021) Outcomes associated with scheduling or up-scheduling controlled substances. International Journal of Drug Policy 91, pages 103110.
Crossref
Rachel A. McKennaAlfred LeeChen YanGiap H. VuEllen C. JantzenPatrick J. BrennanAdam WatsonCaroline BurlingameInes C. Lin. (2021) Effective Reduction in Opioid Prescriptions for Ambulatory Lesion Excisions in Pediatric Patients. Plastic and Reconstructive Surgery - Global Open 9:3, pages e3466.
Crossref
Silken A. Usmani, Josef Hollmann, Amie Goodin, Juan M. Hincapie-Castillo, Lauren E. Adkins, Natalie Ourhaan, Razanne Oueini, Hemita Bhagwandass, Taylor Easey & Scott Martin Vouri. (2021) Effects of hydrocodone rescheduling on opioid use outcomes: A systematic review. Journal of the American Pharmacists Association 61:2, pages e20-e44.
Crossref
Jody L. Green, Taryn Dailey-Govoni & Stephen F. Butler. (2020) Real-World Data on Nonmedical Use of Tramadol from Patients Evaluated for Substance Abuse Treatment in the NAVIPPRO Addiction Severity Index—Multimedia Version (ASI-MV®) Network. Drug Safety 44:2, pages 235-244.
Crossref
Craig S. Miller, Chenlu Ke, Jeffrey T. Witty & Radha Nagarajan. (2020) Prescribing patterns of opioid analgesics in a dental setting: 2013–2018. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology 130:4, pages 402-410.
Crossref
Anthony D. Mahairas, Ryan Neff, Nikki Craker, Beth N. McNulty, Jennifer B. Shinn & Matthew L. Bush. (2020) Trends in Opioid Usage Following Tympanoplasty and Mastoidectomy. Otology & Neurotology 41:8, pages e1035-e1040.
Crossref
Anthony D. Mahairas, Ryan Neff, Nikki Craker, Beth N. McNulty, Jennifer B. Shinn & Matthew L. Bush. (2020) Opioid Prescribing Patterns and Usage Following Cochlear Implantation. Otology & Neurotology 41:7, pages 922-928.
Crossref
Gary Wynn, Rakesh Jetly, Eric Vermetten, Shawn Rhind & Wayne Willmott. (2020) Pharmacogenomics: A primer for the military mental health provider. Journal of Military, Veteran and Family Health 6:S1, pages 44-50.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.